The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Neuromuscular Research Funding Announcements From Jesse’s Journey and Muscular Dystrophy Canada

The NMD4C is excited to share recent grant funding announcements from two of our partners, Jesse’s Journey and Muscular Dystrophy Canada. The network is incredibly fortunate to be able to collaborate with these incredible organizations, and it is our pleasure to recognize the contributions of each towards helping to fund neuromuscular research.

 

Jesse’s Journey

Jesse’s Journey, Canada’s leader in Duchenne muscular dystrophy funded research, will grant $1.7M toward four promising research projects this year – the largest annual amount in its 26-year history.

 

Newly funded projects in 2021 include:

Dr. Niclas Bengtsson: Development of gene regulatory cassettes that enable safe- and efficient in vivo dystrophin gene-editing in muscle stem cells.

Dr. Natasha Chang: Inducing stress granule formation in muscle stem cells to treat DMD.

Dr. Ronald Cohn: Simultaneous DMD gene editing and upregulation to restore protective levels of full-length dystrophin in the treatment of DMD duplication mutations.

Dr. Sachiko Sato: Development of a Monosaccharide Therapy Using N-Acetylglucosamine to Mitigate Duchenne Muscular Dystrophy.

 

The growth in scientific funding interest is encouraging for the community because it means there is an increasing commitment to Duchenne science and drug discovery, bringing hope and progress towards prevention, treatment, and ultimately – a cure.

Read the full press release from Jesse’s Journey here!

 

Muscular Dystrophy Canada

Muscular Dystrophy Canada (MDC) has announced an investment of $400,000 to fund seven new research projects in 2021 through the MDC Neuromuscular Disorder (NMD) Research Grant Competition, a dedicated Canadian source of funding for neuromuscular research. MDC will also invest in an international, collaborative, $1.15 million, research project through the European Joint Programme on Rare Diseases (EJP RD).

 

The 2020-2021 research grant recipients are:

Dr. Alex Parker: A Pharmacogenetic Pipeline for Charcot-Marie-Tooth Disease

Dr. Colin Crist: Promoting Muscle Repair by Pharmacological Inhibition of eIF2a Dephosphorylation

Dr. Mohamed Chahine: Human iPSC-derived Neurons as a Model of Congenital Myotonic Dystrophy Type 1

Dr. Nadine Wiper-Bergeron: Improving Myoblast Transplantation Outcomes via Pharmacological Reprogramming

Dr. Nicolas Dumont: Targeting Defective Stem Cells in a Preclinical Model of Myotonic Dystrophy Type 1

Dr. Rima Al-Awar (EJPRD/CIHR Co-funded): Safety and Efficacy of a Possible Epigenetic Therapy for Facioscapulohumeral Muscular Dystrophy

Dr. Toshifumi Yokota: Enhancing the Efficacy of Antisense Oligonucleotide Therapy for Facioscapulohumeral Muscular Dystrophy

 

Read the full press release from Muscular Dystrophy Canada here!

MDC_JJ

Read next...

KT infographic logo

Knowledge Translation Team Share Clinical Practice Guideline Infographic

The Knowledge Translation team are are glad to share an infographic of the clinical practice guideline “Promoting Sexuality and Intimate Relationships in Adults with a NMD in Occupational Therapy”

Upcoming neuromuscular conferences

Upcoming Neuromuscular Conferences in 2022

This year we are excited to anticipate the return of in-person conferences, which provide an invaluable training and networking experience to all members of the neuromuscular community and which have been dearly missed over the past two years. In 2022, Canada will host several major neuromuscular conferences, both domestic and international. Please take a moment…

Knowledge Translation Canada logo

Network’s Approach to Adapting Knowledge Translation Strategies for Neuromuscular Diseases: Knowledge Translation Canada Scientific Meeting

on behalf of the NMD4C Knowledge Translation team, Drs. Cynthia Gagnon and Homira Osman have had a poster presentation accepted for inclusion at the Knowledge Translation Canada (KT Canada) 2022 Virtual Scientific Meeting.

Dr. Emanuela Pannia EC Blog

Read NMD4C and MDC Postdoc Fellowship Recipient Dr. Emanuela Pannia’s Early-Career Blog

Read the latest early career blog post, from NMD4C and MDC Postdoc Fellowship Recipient Dr. Emanuela Pannia.

Clinical practice guideline in NMD infographic logo

Knowledge Translation Team Infographic “Consensus-based Care Recommendations for Children with Myotonic Dystrophy Type 1”

The Knowledge Translation team are are glad to share an infographic of the Myotonic Dystrophy Foundation’s “Consensus-based Care Recommendations for Children with Myotonic Dystrophy Type 1“, with the contribution of Dr. Craig Campbell (NMD4C investigator). The infographic shares a few key clinical points to consider and offers direct link and QR code to download the complete guideline.

CoP-MDC

Community of Practice for Neuromuscular Allied Healthcare Members: MDC and NMD4C Begin Consultations

The Neuromuscular Disease Network for Canada in partnership with Muscular Dystrophy Canada, is investigating ways to better support allied healthcare professionals that work with clients/patients affected by neuromuscular disorders and their families. We wish to introduce and implement a Community of Practice for allied healthcare professionals this year, but first we would like to complete a needs assessment and seek your valued input.